The Global VEGF-A Inhibitors Market is experiencing robust growth. Valued at USD 10.49 billion in 2024, the market is projected to reach USD 17.02 billion by 2032, expanding at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2032. This article delivers a detailed examination of market dynamics, segmentation, drivers, challenges, and competitive strategies, drawing...